Viewing Study NCT04414969


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-05-19 @ 8:54 AM
Study NCT ID: NCT04414969
Status: UNKNOWN
Last Update Posted: 2020-07-07
First Post: 2020-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma
Sponsor: Hunan Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune Checkpoint Inhibitor View
None Chemotherapy Effect View
None Epigenetic Disorder View
None NK/T-cell Lymphoma of Nasal Cavity View
Keywords: